Vimarsana
Biggest News Aggregation in the World

Page 3 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

COMPASS Pathways plc (NASDAQ:CMPS) Short Interest Update - Vimarsana News

COMPASS Pathways plc (NASDAQ:CMPS) Short Interest Update

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 3,340,000 shares, an increase of 6.7% from the March 31st total of 3,130,000 shares. Based on an average trading volume of 705,600 shares, the days-to-cover ratio […]

Reunion raises over $100M to build a better psychedelic drug - Vimarsana News

Reunion raises over $100M to build a better psychedelic drug

BioPharma

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment - Vimarsana News

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

LONDON, May 02, 2024 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Mindful Health Solutions , one of...

Cantor Fitzgerald Reiterates Overweight Rating for COMPASS Pathways (NASDAQ:CMPS) - Vimarsana News

Cantor Fitzgerald Reiterates Overweight Rating for COMPASS Pathways (NASDAQ:CMPS)

COMPASS Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at Cantor Fitzgerald in a note issued to investors on Tuesday, Benzinga reports. Other research analysts have also issued reports about the stock. HC Wainwright reissued a “buy” rating and set a $120.00 price target on shares of COMPASS […]

COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by Cantor Fitzgerald - Vimarsana News

COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by Cantor Fitzgerald

COMPASS Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. A number of other equities research analysts also recently commented on CMPS. HC Wainwright restated a “buy” rating and issued a $120.00 price objective on shares […]